Cardinal Health has reached a definitive agreement to acquire the diabetes health business of AdaptHealth and the specialty medical supplier Strive Medical, marking a significant acceleration in the healthcare giant’s multi-year strategy to dominate the burgeoning at-home care market. The dual acquisition, announced on July 22, 2026, represents a combined investment of approximately $360 million, further solidifying Cardinal Health’s position as a premier provider of medical supplies delivered directly to patients’ doorsteps.
Under the terms of the agreements, Cardinal Health will pay $235 million for AdaptHealth’s diabetes unit. While the specific price for Strive Medical was not explicitly detailed in the initial announcement, the financial structure of the deal implies an acquisition cost of roughly $125 million. These moves are designed to bolster Cardinal’s At-Home Solutions business, a segment that has become a primary engine of growth for the Dublin, Ohio-based corporation.
Strategic Rationale and the Shift Toward Home-Based Care
The healthcare industry has undergone a seismic shift over the last five years, moving away from centralized hospital-based care toward decentralized, home-based models. This transition is driven by a confluence of factors, including an aging population, the rising prevalence of chronic conditions, and a reimbursement landscape that increasingly favors cost-effective outpatient settings. Cardinal Health’s latest acquisitions are a direct response to these macroeconomic trends.
The At-Home Solutions unit at Cardinal Health has emerged as a standout performer in the company’s "Other" reporting segment. By acquiring AdaptHealth’s diabetes business, Cardinal adds a robust infrastructure that serves more than 225,000 patients annually. This business primarily focuses on the distribution of continuous glucose monitors (CGMs) and insulin pumps—technologies that have become the gold standard for managing Type 1 and Type 2 diabetes.
Simultaneously, the acquisition of Strive Medical allows Cardinal to diversify its portfolio beyond diabetes. Strive Medical specializes in urology, wound care, ostomy, and incontinence supplies, serving over 20,000 customers per year. This expansion into specialty medical products provides Cardinal with a more comprehensive suite of offerings for patients with complex, chronic needs, effectively turning the company into a "one-stop shop" for home medical equipment (HME).
Financial Performance and Segment Growth
The financial impetus for these acquisitions is rooted in the recent performance of Cardinal Health’s at-home business. In the third quarter of the 2026 fiscal year, the unit contributed $1.7 billion in revenue. More impressively, the segment helped drive a 34% year-over-year increase in profit within its specific business unit. This outperformance led Cardinal Health leadership to raise profit guidance for the remainder of the fiscal year, signaling high confidence in the sustainability of home-based medical supply demand.
Executives noted that the integration of previous acquisitions has paved the way for this current expansion. In April 2025, Cardinal Health completed the $1.1 billion acquisition of Advanced Diabetes Supply (ADS). That deal added nearly 500,000 customers to Cardinal’s roster and integrated into the company’s operations faster than internal projections suggested. The success of the ADS integration served as a proof-of-concept for the current purchase of AdaptHealth’s diabetes unit.
By folding these new assets into its existing logistical framework, Cardinal Health expects to achieve significant synergies. The company’s global medical products and distribution arm already possesses one of the most sophisticated supply chains in the world; leveraging this to deliver specialized diabetes and urological supplies directly to consumers allows for higher margins than traditional wholesale distribution to hospitals.
A Chronology of Strategic Expansion
Cardinal Health’s pivot toward at-home solutions and specialty care has been a calculated, multi-step process. To understand the significance of the July 2026 announcement, one must look at the timeline of the company’s recent mergers and acquisitions (M&A) activity:
- April 2025: Cardinal Health completes the $1.1 billion acquisition of Advanced Diabetes Supply (ADS), a major direct-to-patient provider. This established Cardinal as a top-tier player in the CGM and insulin delivery market.
- August 2025: The company acquires Solaris Health, a leading urology multi-specialty organization (MSO). This move signaled Cardinal’s intent to move deeper into specialized clinical pathways, beyond just distribution.
- March 2026: Cardinal reports record-breaking third-quarter earnings for its at-home segment, fueled by the rapid onboarding of ADS customers and increased demand for home-based chronic care management.
- July 2026: The company announces the dual acquisition of AdaptHealth’s diabetes business and Strive Medical, further consolidating the market and expanding its specialty product reach.
This timeline illustrates a clear trajectory: Cardinal Health is no longer content being just a middle-man in the pharmaceutical supply chain. It is aggressively positioning itself as a direct healthcare partner for patients managing long-term conditions.
The Diabetes Market Context
The acquisition of AdaptHealth’s diabetes business comes at a time when the diabetes care market is experiencing unprecedented technological growth. According to data from the Centers for Disease Control and Prevention (CDC), over 38 million Americans have diabetes, and approximately 1 in 3 adults have prediabetes. As the population ages and obesity rates remain high, the demand for management tools is projected to grow steadily through 2030.
The shift from traditional finger-stick blood glucose tests to Continuous Glucose Monitors (CGMs) has revolutionized the industry. CGMs provide real-time data to patients and physicians, improving outcomes and reducing hospitalizations. However, these devices require a consistent, reliable supply chain for sensors and transmitters. By acquiring a business that serves 225,000 patients, Cardinal Health is securing a recurring revenue stream in a high-demand, tech-driven medical niche.
Furthermore, the divestiture by AdaptHealth is equally telling. AdaptHealth, a major player in the home medical equipment space, appears to be streamlining its own portfolio to focus on core competencies, likely in respiratory and sleep therapy. The $235 million cash infusion from Cardinal allows AdaptHealth to deleverage its balance sheet or reinvest in its primary business lines, while Cardinal gains a ready-made patient base.
Expanding into Urology and Wound Care via Strive Medical
While the diabetes acquisition captures the headlines due to the dollar amount, the purchase of Strive Medical is strategically vital for diversification. The urology and wound care markets are often overlooked but represent essential, non-discretionary spending. Patients requiring ostomy or incontinence supplies often need them for the duration of their lives, creating a stable and predictable demand profile.
Strive Medical’s focus on urology complements Cardinal’s 2025 acquisition of Solaris Health. By owning both a urology MSO (Solaris) and a urology supply distributor (Strive), Cardinal Health is vertically integrating its services. This allows the company to influence the entire patient journey—from the physician’s recommendation in a Solaris-affiliated clinic to the delivery of the product via Cardinal’s at-home logistics.
Industry Implications and Future Outlook
Industry analysts view Cardinal Health’s recent moves as a defensive and offensive play against competitors like McKesson and Medline, as well as retail giants like Amazon and CVS, which have also signaled interest in the home health space. By securing specialized distribution networks and direct-to-patient relationships, Cardinal is building a "moat" around its at-home business.
The implications for the broader healthcare system are significant. As Cardinal Health scales its at-home operations, it can offer more competitive pricing to insurers and Medicare. The efficiency of direct-to-home delivery reduces the overhead costs associated with traditional retail pharmacy or hospital-based distribution. For patients, this means easier access to life-sustaining supplies and a more seamless management of chronic conditions.
However, the rapid consolidation of the HME market also raises questions about patient choice and market competition. As Cardinal Health absorbs smaller, specialized players like Strive Medical and ADS, it becomes one of the few dominant entities capable of operating at a national scale. This scale is necessary to navigate the complexities of Medicare reimbursement, but it also places a significant amount of market power in the hands of a single corporation.
Looking forward, Cardinal Health’s "Other" segment—which includes at-home solutions, freight logistics, and other specialty units—is expected to become an even larger portion of the company’s total revenue. The company’s ability to successfully integrate the AdaptHealth and Strive Medical assets will be a key metric for investors in the coming fiscal years.
Conclusion
Cardinal Health’s $360 million investment in AdaptHealth’s diabetes business and Strive Medical is a clear affirmation of its commitment to the "hospital-at-home" movement. By focusing on high-growth, high-margin sectors like diabetes technology and specialty urology supplies, Cardinal is evolving its business model to meet the needs of a changing demographic. As the healthcare landscape continues to prioritize home-based care, Cardinal Health’s strategic acquisitions position it as a central pillar in the infrastructure of modern American medicine. The closing of these deals, pending regulatory approval, will mark the next chapter in the company’s transformation from a traditional distributor to a comprehensive at-home healthcare provider.
